Anti-TLR4 antibody significantly blocks the activation of monocytes by synovial fluid from RA patients exhibiting ACPAs (9), suggesting involvement of the TLR4-mediated pathway in the pathogenesis of RA. This evidence concerns the gene TLR4 and rheumatoid arthritis.